Comparison of the Ambu AuraGain and Intersurgical i-Gel Laryngeal Masks in Elective Laparoscopic Cholecystectomy
A Prospective, Controlled and Randomized Comparison of the Ambu AuraGain and Intersurgical i-Gel Laryngeal Masks in Elective Laparoscopic Cholecystectomy
1 other identifier
interventional
88
1 country
1
Brief Summary
Prospective, controlled, randomized study to compare Ambu AuraGain with Intersurgical i-Gel mask during mechanical ventilation in patients undergoing laparoscopic cholecystectomy. The investigators hypothesise that when comparing the Ambu® AuraGainTM with Intersurgical i-GelTM mask, the Ambu® AuraGainTM would exhibit a higher oropharyngeal leak pressure (OLP) during mechanical ventilation in patients undergoing laparoscopic cholecystectomy. The main goal is to compare the Ambu AuraGain with the i-Gel in terms of safety and efficacy during mechanical ventilation in critical phase of the pneumoperitoneum in lateral decubitus and reverse trendelemburg position. Secondary objectives are comparing insertion time, number of attempts, ventilatory airway peak pressure, time and success rates for gastric tube insertion and the incidence of side effects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 18, 2019
CompletedFirst Submitted
Initial submission to the registry
December 18, 2019
CompletedFirst Posted
Study publicly available on registry
December 20, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 17, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 9, 2020
CompletedFebruary 16, 2021
November 1, 2019
3 months
December 18, 2019
February 14, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Oropharyngeal leak pressure pneumoperitoneum.
Oropharyngeal Leak Pressure (OLP) will be measured by closing the expiratory valve of the circle system at a fixed gas flow of 3 litres/min (maximum allowed 40 cmH2O) recording the pressure at which equilibrium has been reached or audible air is leaking.
10 month
Study Arms (2)
i Gel LMA
ACTIVE COMPARATORThe sealing pressure of the igel laryngeal mask will be measured during pneumoperitoneum in elective laparoscopic cholecystectomy
Ambu Aura Gain
ACTIVE COMPARATORIt will be compared the Ambu Aura Gain LMA vs iGel in elective laparoscopic cholecystectomy
Interventions
Oropharyngeal Leak Pressure (OLP) will be measured by closing the expiratory valve of the circle system at a fixed gas flow of 3 litres/min (maximum allowed 40 cmH2O) recording the pressure at which equilibrium has been reached or audible air is leaking.
Eligibility Criteria
You may qualify if:
- Patients aged 18-80 year
- American Society of Anaesthesiologists physical status I-III
- Elective Laparoscopic Cholecystectomy
You may not qualify if:
- Previous knowledge of difficult intubation
- Mouth opening less than 35 mm
- Cervical spine disease
- BMI≥35 kg/m2
- Upper respiratory or digestive tract disease
- Severe obstructive pulmonary disease
- Recent history of upper respiratory tract infection
- Pregnancy
- Patients who have a risk of gastric aspiration
- Preoperative sore throat
- Patients who refuse to participate
- Withdrawal criterion:
- Orotracheal intubation during surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hospital Platólead
Study Sites (1)
Anesthesia Department, Hospital Plató
Barcelona, 08006, Spain
Study Officials
- PRINCIPAL INVESTIGATOR
Teresa García-Navia
Hospital Plato
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 18, 2019
First Posted
December 20, 2019
Study Start
November 18, 2019
Primary Completion
February 17, 2020
Study Completion
March 9, 2020
Last Updated
February 16, 2021
Record last verified: 2019-11
Data Sharing
- IPD Sharing
- Will not share
All IPD that underlie results in a publication